AE Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-788
Closed -$209K 1792
2021
Q4
$209K Buy
788
+38
+5% +$10.2K ﹤0.01% 1589
2021
Q3
$217K Buy
+750
New +$192K ﹤0.01% 1507
2021
Q2
Sell
-4,996
Closed -$971K 1663
2021
Q1
$971K Buy
4,996
+1,024
+26% +$210K 0.01% 782
2020
Q4
$761K Sell
3,972
-747
-16% -$136K 0.01% 804
2020
Q3
$696K Buy
+4,719
New +$675K 0.01% 743

Other funds holding RGEN

AE Wealth Management's RGEN Position: Q1 2022 in Review

AE Wealth Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 788 shares — an estimated $209K sold.

AE Wealth Management first reported a position in RGEN in Q3 2020 and held it in 5 quarters. The position peaked at $971K in Q1 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • AE Wealth Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • AE Wealth Management sold 788 Repligen shares in Q1 2022, an estimated $209K.
  • AE Wealth Management first reported a position in Repligen in Q3 2020 and held it in 5 quarters.
  • AE Wealth Management's Repligen position peaked at $971K in Q1 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on AE Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.